Clinical Trial Update: Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating S 47445 as an adjunctive treatment to current antidepressant therapy in adults with major depressive disorder; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• S 47445

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED